Innovex International (INVX) Cost of Revenue (2009 - 2026)

Innovex International (INVX) has 18 years of Cost of Revenue data on file, last reported at $154.5 million in Q1 2026.

• Quarterly Cost of Revenue fell 5.73% year-over-year to $154.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $665.6 million (up 29.7% YoY) and the FY2025 annual result came in at $675.0 million, up 57.64% from the prior year.
• Cost of Revenue declined to $154.5 million in Q1 2026, from $194.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $194.5 million in Q4 2025 to a low of $64.0 million in Q1 2022.
• A 5-year average of $110.1 million and a median of $89.2 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue slipped 22.76% — and 2025, when it soared 107.73%.
• Tracing INVX's Cost of Revenue over 5 years: stood at $109.7 million in 2022, then fell by 22.76% to $84.7 million in 2023, then jumped by 95.68% to $165.8 million in 2024, then rose by 17.29% to $194.5 million in 2025, then declined by 20.55% to $154.5 million in 2026.
• The last three Cost of Revenue figures came in at $154.5 million (Q1 2026), $194.5 million (Q4 2025), and $164.1 million (Q3 2025), per Business Quant data.